Live Research Database
Eczema
Hub: Kew Gardens, NY
Connecting patients in Kew Gardens with breakthrough clinical trials, specialized care, and study-related compensation.
+4k
Join 4,200+ participants tracking trials in New York
Available Eczema Opportunities
4 RecruitingNCT07265479(Verify)
A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis
RECRUITING
Eczema
NCT07037901(Verify)
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
RECRUITING
Eczema
NCT06863961(Verify)
A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis
RECRUITING
Eczema
NCT06389136(Verify)
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
RECRUITING
Eczema
Patient Safeguards
IRB Oversight
Ethics Committee Approved
HIPAA Compliant
Full Data Privacy
NIH Standards
Global Quality Benchmarks
"Advancing Eczema research in Kew Gardens through safe, transparent, and patient-first clinical trials."
Eczema Hubs in NY
Regional Network of Excellence
ClinicalTrials.govFDA REGISTEREDIRB OVERSIGHTHIPAA COMPLIANT